According to FibroGen's latest financial reports the company's current earnings are HK$29.62 Million. , an increase over its 2023 earnings that were of -HK$2.23 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -HK$1.19 Billion | -46.54% |
2023 | -HK$2.23 Billion | -2.71% |
2022 | -HK$2.29 Billion | 1.44% |
2021 | -HK$2.26 Billion | 53.87% |
2020 | -HK$1.47 Billion | 146.49% |
2019 | -HK$0.6 Billion | -11% |
2018 | -HK$0.67 Billion | -20.84% |
2017 | -HK$0.85 Billion | 76.16% |
2016 | -HK$0.48 Billion | -27.81% |
2015 | -HK$0.67 Billion | 43.75% |
2014 | -HK$0.47 Billion |